# HURA: TuHURA Biosciences, Inc. Common Stock

- Industry: Pharmaceutical Preparations
- Current price: $2.1
- Price updated: Sep 19, 2026
- Total congressional trades: 1
- Politicians trading: 1
- Last traded: Jul 13, 2025
- Source: https://tryglasshouse.ai/companies/HURA.md

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

# Congressional trading history

- Page: 1 of 1
- Results: 1 of 1
- Pagination query parameter: `page`

## 1. Laurel M. Lee

- Member: Republican, House
- Transaction: Buy, $50,001 - $100,000
- Dates: traded Jul 13, 2025, disclosed Aug 9, 2025
- Market context: $2.3 at trade, $2.1 current (-8.70%)
- Politician: https://tryglasshouse.ai/politicians/L000597.md
- Record: https://tryglasshouse.ai/trades/be4b35dc-9cb0-418d-b790-548e536a99f2.md



Prices and percentage changes are market context, not portfolio returns. This information is not financial advice.